Salesforce
CRM
Coinbase
COIN
Oracle
ORCL
4
Tesla
TSLA
5
Microsoft
MSFT
US Stock MarketDetailed Quotes
ORKA Oruka Therapeutics
- 10.500
- -0.080-0.76%
Close Apr 24 16:00 ET
- 11.020
- +0.520+4.95%
Post 16:11 ET
393.13MMarket Cap-27.63P/E (TTM)
10.880High9.825Low207.66KVolume10.670Open10.580Pre Close2.13MTurnover0.89%Turnover RatioLossP/E (Static)37.44MShares33.00052wk High1.04P/B245.76MFloat Cap5.48552wk Low--Dividend TTM23.41MShs Float40838270.811Historical High--Div YieldTTM9.97%Amplitude5.485Historical Low10.249Avg Price1Lot Size
Oruka Therapeutics Key Stats
EPS
According to the latest financial report of Oruka Therapeutics, the latest earnings per share (TTM) for the company is -1.46. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Oruka Therapeutics's free cash flow? The latest report shows it as --. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Oruka Therapeutics shows that the company's current ratio is 22.89, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Oruka Therapeutics, the quick ratio is 22.78, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Oruka Therapeutics? The latest ROE figure is -8.43%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Oruka Therapeutics, the total asset return on investment (ROA) is -6.91%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Oruka Therapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Oruka Therapeutics, the net profit margin is --, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025